Faculty

Diana Buist

Affiliate Professor, Epidemiology


dsmbuist@gmail.com

Education

PhD Epidemiology, University of Washington, 1999
MPH Epidemiology, Yale University, 1995

Contact


dsmbuist@gmail.com

Seattle, WA

Bio

Diana Buist, PhD, MPH, is an epidemiologist and health services researcher with extensive experience conducting comparative effectiveness research. Her work focuses on reducing harms and increasing benefits for patients in the area of cancer screening and outcomes spanning across patient, provider, and system factors.

Dr. Buist has an extensive record of practical research that has led to many efforts to improve care, including the development and refinement of national breast cancer screening guidelines. She has been conducting research within Kaiser Permanente Washington for more than 20 years and is a strong believer in patient-centered care and the important role patients play in improving the value and quality of health care.

Research Interests

  • Comparative effectiveness research
  • Delivery system science
  • Learning health care system research
  • Dissemination and implementation
  • Pragmatic clinical trials
  • Epidemiology
  • Health services

Recent Publications (PubMed)

Patient and Nodule Characteristics Associated with a Lung Cancer Diagnosis Among Individuals with Incidentally Detected Lung Nodules.
(2022 Sep 30)
Chest
Farjah F, Monsell SE, Greenlee RT, Gould MK, Smith-Bindman R, Banegas MP, Schoen K, Ramaprasan A, Buist DSM

Fleischner Society Guideline Recommendations for Incidentally Detected Pulmonary Nodules and the Probability of Lung Cancer.
(2022 Aug 29)
J Am Coll Radiol
Farjah F, Monsell SE, Smith-Bindman R, Gould MK, Banegas MP, Ramaprasan A, Schoen K, Buist DSM, Greenlee R

Accuracy of tumor registry versus pharmacy dispensings for breast cancer adjuvant endocrine therapy.
(2022 Sep)
Cancer Causes Control 33(9): 1145-1153
Haas CB, Bowles EJA, Lee JM, Specht J, Buist DSM

Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density.
(2022 Aug)
Breast Cancer Res Treat 194(3): 607-616
Wernli KJ, Smith RE, Henderson LM, Zhao W, Durham DD, Schifferdecker K, Kaplan C, Buist DSM, Kerlikowske K, Miglioretti DL, Onega T, Alsheik NH, Sprague BL, Jackson-Nefertiti G, Budesky J, Johnson D, Tosteson ANA

Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
(2022 Jun 14)
JAMA 327(22): 2220-2230
Kerlikowske K, Su YR, Sprague BL, Tosteson ANA, Buist DSM, Onega T, Henderson LM, Alsheik N, Bissell MCS, O'Meara ES, Lee CI, Miglioretti DL

Show complete publication list